Sponsor or institution
Clinical trials and research at Pdx Pharmaceuticals, INC.
As of November 12, 2026, Find a Trial lists 5 NIH-funded research projects at this institution, with $3.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5NIH research projects
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Nanoparticle Immunotherapy for Lung Cancer
This project is developing a new nanoparticle-based immunotherapy called ARAC-02 to improve outcomes for people with non-small cell lung cancer.
-
A New Nanoparticle Treatment for Lung Cancer
This project develops a tiny particle that targets lung cancer cells to deliver a special medicine, aiming to improve treatment for patients.
-
Targeting lung cancer with a new nanotherapy that enhances radiation treatment
This study is testing a new treatment called PETTRA that aims to help people with lung cancer by targeting specific tumors and making radiation therapy work better, all while focusing on keeping the treatment safe and effective.
-
Developing a new nanoparticle-based treatment for non-small cell lung cancer
This study is testing a new treatment called ARAC-02 for people with non-small cell lung cancer, using tiny particles to deliver a mix of medicines directly to the tumors to help the immune system fight the cancer better.
-
New treatment approach for non-small cell lung cancer using nano-immunotherapy
This study is testing a new treatment called ARAC that uses tiny particles to help boost the power of current therapies for non-small cell lung cancer, aiming to make them work better and improve survival for patients.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.